ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1907

T-Bet Regulates Ahr-Mediated Th-17 Differentiation Independently of IFNγ

Masahiro Yokosawa, Yuya Kondo, Shunta Kaneko, Seiji Segawa, Hiroto Tsuboi, Isao Matsumoto and Takayuki Sumida, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: T cells and transcription factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Poster Session I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Our previous reports showed that the development of collagen-induced arthritis was suppressed in T-bet transgenic (T-bet Tg) mice. The regulatory mechanism might relate to dysfunction of Th-17 cell differentiation by the overexpression of T-bet gene. The purpose of this study is to clarify the effect of T-bet overexpression on Th-17 cell differentiation.

Methods:   T-bet overexpressing IFNγ deficient (T-bet Tg/IFNγ-/-) mice were generated by crossing T-bet Tg mice under the promoter of CD2 gene with IFNγ deficient (IFNγ-/-) mice. CD4+ T cells from C57BL/6 (WT), T-bet Tg, or T-bet Tg/IFNγ-/- mice were cultured for Th-17 differentiation, and the cytokine production (IFNγ, IL-17) and the expression of transcription factors (T-bet, RORγt) was analyzed. We examined the expression of IL-6 receptor (IL-6R) constituted by CD126 and CD130 and the phosphorylation of STAT3 by IL-6 stimulation of CD4+ T cells. The mRNA expression of transcription factors (tbx21, rorc, stat3, stat1, runx1, irf4, nfkbiz, and ahr) associated with the Th-17 differentiation were examined in the Th-17 condition. We transduced retrovirus expressing T-bet gene into naïve CD4+ T cells of WT or IFNγ-/- mice, and investigated cytokines and transcription factors expression. Moreover, we examined the expression of aryl hydrocarbon receptor (AHR) in Th-17 condition by flow cytometry in both T-bet Tg mice and retroviral transduction of T-bet gene. We investigated the facilitation of Th-17 differentiation by the addition of AHR ligand, 6-formylindolo [3,2-b] carbazole (FICZ), and analyzed the mRNA expression of cyp1a1, which was the AHR target gene.

Results:   In both T-bet Tg and T-bet Tg/IFNγ-/- mice, RORγt expression and IL-17 production were inhibited in Th-17 condition, and IL-6R expression and STAT3 phosphorylation of CD4+ T cells were decreased. We also observed the inhibition of IL-17 production in CD4+ T cells of WT and IFNγ-/- mice transduced with T-bet, whereas T-bet transduction in vitro had no effects on IL-6 receptor expression and STAT3 phosphorylation. The mRNA expression of nfkbiz was up-regulated, but rorc and ahr were down-regulated with T-bet overexpression in both T-bet Tg mice and T-bet gene transduction under the Th-17 condition. FACS analyses revealed that the expression of AHR was significantly decreased not only in T-bet Tg and T-bet Tg/IFNγ-/- mice but also in T-bet gene transduced cells from both WT and IFNγ-/- mice. IL-17 production and the expression of cyp1a1 by T-bet overexpression were not promoted by the addition of FICZ.

Conclusion:   T-bet overexpression in CD4+ T cells repressed Th-17 differentiation by suppression of IL-17 production, RORgt expression, and AHR expression. Our findings support the possibility that regulatory mechanisms of Th-17 differentiation by T-bet overexpression might be due to the IFNγ-independent suppression of AHR.


Disclosure: M. Yokosawa, None; Y. Kondo, None; S. Kaneko, None; S. Segawa, None; H. Tsuboi, None; I. Matsumoto, None; T. Sumida, None.

To cite this abstract in AMA style:

Yokosawa M, Kondo Y, Kaneko S, Segawa S, Tsuboi H, Matsumoto I, Sumida T. T-Bet Regulates Ahr-Mediated Th-17 Differentiation Independently of IFNγ [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/t-bet-regulates-ahr-mediated-th-17-differentiation-independently-of-ifn%ce%b3/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/t-bet-regulates-ahr-mediated-th-17-differentiation-independently-of-ifn%ce%b3/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology